A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B

Inclusion Criteria: * Diagnosis of moderate or severe congenital Hemophilia A or B with or without inhibitors Exclusion Criteria: * Diagnosis of any coagulation disorder other than Hemophilia A or B * Receipt of any immunomodulatory therapy within 3 months prior to screening, with the exception of Hepatitis C or HIV therapy * Have had, within one month prior to study drug administration, a major surgical procedure (e.g. orthopedic, abdominal) or have an elective surgery planned within the study period * Use of any anticoagulant for arterial/venous obstructions and/or atrial fibrillation within 7 days prior to first study drug administration * Malignancy within past 5 years (excluding non-melanoma skin cancer)